Vijay Karwal

Managing Director at CBC Group

Speaker

Vijay Karwal is a Managing Director of CBC Group, based in Singapore. In his role, he advises on sourcing and execution of investment opportunities as well as portfolio management, leading regional Southeast Asia coverage for the firm, together with providing global origination support for CBC's royalty & credit strategy RBF funds. Vijay was previously an Operating Partner of CBC in which capacity he served as Executive Director and CEO of AffaMed Therapeutics, a Shanghai headquartered CBC portfolio company developing innovative solutions for ophthalmic disorders, which he first joined as CFO. He contributes over 25 years of global management and advisory experience in the healthcare industry with extensive background in strategy, business development, M&A and capital raising gained in roles in industry and as a senior investment banker. He currently serves as a Director of CBC portfolio companies Dawn Medical Technologies, AffaMed Therapeutics and Motiva China, as well as CBC's healthcare infrastructure (HIP) real estate fund management platform, and is also an Independent Director of Mega Lifesciences PCL, one of the largest pharmaceutical groups in Southeast Asia, stock exchange listed and headquartered in Thailand, and OneSource Specialty Pharma Ltd, a leading global biologics and specialty pharma CDMO, stock exchange listed and headquartered in India.

Vijay joined CBC from Nomura International in Hong Kong, where he served as Managing Director and Head of Healthcare Investment Banking for the Asia (ex-Japan) region. Prior to Nomura, he was Chief Development Officer, Asia Pacific, as well as General Manager of China operations for DaVita Inc., the NYSE-listed global provider of kidney care services. Vijay previously held several senior investment banking roles globally, including as Co-Head of M&A at CIMB Investment Bank, Asia Pacific Head of Consumer, Retail & Healthcare coverage at RBS, Head of Healthcare Banking in North America at ABN AMRO and RBS, and as a senior member of ABN AMRO Rothschild - the global equity capital markets joint venture between the Rothschild and ABN AMRO groups. Throughout his career he has been involved in a wide variety of advisory and financing transactions in the healthcare sector representing over $95 billion in transaction value, gaining extensive global experience across postings in London, Chicago, New York, Hong Kong and Singapore.

A native of the Netherlands, Vijay was educated at the University of Southampton, UK, and the University of Groningen, the Netherlands, holds a M.Sc. in Economics, and is also a CFA charter holder.